Arsanis' Grant

Arsanis raised a round of funding on October 20, 2011. Investors include FFG.

Arsanis is a clinical-stage company creating precision monoclonal antibodies for the prevention and treatment of serious bacterial infections not effectively controlled by currently available treatmen…

Articles about Arsanis' Grant: